Cipla's arm acquires 30% stake in Brandmed

30 Apr 2019 Evaluate

Cipla's wholly owned subsidiary -- Cipla Medpro South Africa (Pty) has completed closing of transaction and acquired 30% stake in Brandmed (Pty). Out of the total upfront cash consideration payment of ZAR 65 million, ZAR 50 million has been paid and balance will be paid over a period of next 12 months.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1463.15 2.55 (0.17%)
09-Jan-2026 11:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1749.00
Dr. Reddys Lab 1211.50
Cipla 1463.15
Zydus Lifesciences 904.85
Lupin 2185.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×